CD34 has been used as a marker of TCs (Zurzu et al., 2021); the number of CD34+ TCs in the intestine of rats with ulcerative colitis is significantly decreased, and it gradually increases after drug treatment and the consequent improvement of the symptoms (Arafat et al., 2021). The gene discussed is CD34; the disease is ulcerative colitis.